Actively Recruiting
The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study
Led by Yonsei University · Updated on 2019-03-18
3100
Participants Needed
1
Research Sites
770 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1\. Purpose of the study 1\) To explore clinical recurrence associated clinical factors including age, sex, clinical, electrophysiological, anatomical, imaging, and serologic characteristics. 2\) To develop simulation model to predict clinical recurrence and the efficacy of catheter ablation 2. Scientific evidence of the study 1. In atrial fibrillation patients, the maintenance of normal sinus rhythm showed significant reduction of mortality. 2. drug therapy with anti-arrhythmic drug showed many complications and side effect, thus non-drug therapy such as catheter ablation is developed. 3. catheter ablation has been performed for 10years world-wide, and showed superior treatment outcome compared with drug therapy. 4. clinical outcome after catheter ablation is affected not only by age, sex and underlying disease, but also by electrophysiologic, imaging, serologic and electroanatomical remodeling of the heart. However, there are few studies concerning these multifactorial variables. 3\. Study population
CONDITIONS
Official Title
The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing catheter ablation for symptomatic, drug-refractory atrial fibrillation
- Age 19 years or older
You will not qualify if you...
- Patients who do not agree to participate in the study
- Permanent atrial fibrillation resistant to electrical cardioversion
- Atrial fibrillation with valvular disease grade 2 or higher
- Left atrial diameter greater than 60 mm
- Age less than 19 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Severance Hospital
Seoul, South Korea, 120-752
Actively Recruiting
Research Team
H
Hui-Nam Pak, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here